BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24275533)

  • 1. Epidemiological and nonclinical studies investigating effects of iron in carcinogenesis--a critical review.
    Beguin Y; Aapro M; Ludwig H; Mizzen L; Osterborg A
    Crit Rev Oncol Hematol; 2014 Jan; 89(1):1-15. PubMed ID: 24275533
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Does excess iron play a role in breast carcinogenesis? An unresolved hypothesis.
    Kabat GC; Rohan TE
    Cancer Causes Control; 2007 Dec; 18(10):1047-53. PubMed ID: 17823849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The efficacy and safety of current intravenous iron preparations for the management of iron-deficiency anaemia: a review.
    Qunibi WY
    Arzneimittelforschung; 2010; 60(6a):399-412. PubMed ID: 20648931
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A possible link between iron deficiency and gastrointestinal carcinogenesis.
    Prá D; Rech Franke SI; Pegas Henriques JA; Fenech M
    Nutr Cancer; 2009; 61(4):415-26. PubMed ID: 19838913
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Review by expert group in the diagnosis and treatment of anemia in pregnant women. Federación Mexicana de Colegios de Obstetricia y Ginecología].
    Montoya Romero Jde J; Castelazo Morales E; Valerio Castro E; Velázquez Cornejo G; Nava Muñoz DA; Escárcega Preciado JA; Montoya Cossío J; Pichardo Villalón GM; Maldonado Aragón A; Santana García HR; Fajardo Dueñas S; Mondragón Galindo CG; García Lee T; García A; Hernández de Morán M; Chávez Güitrón LE; Jiménez Gutiérrez C;
    Ginecol Obstet Mex; 2012 Sep; 80(9):563-80. PubMed ID: 23243836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron supplementation in the non-dialysis chronic kidney disease (ND-CKD) patient: oral or intravenous?
    Macdougall IC
    Curr Med Res Opin; 2010 Feb; 26(2):473-82. PubMed ID: 20014980
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Iron as a target of chemoprevention for longevity in humans.
    Toyokuni S
    Free Radic Res; 2011 Aug; 45(8):906-17. PubMed ID: 21615276
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Disorders associated with systemic or local iron overload: from pathophysiology to clinical practice.
    Sebastiani G; Pantopoulos K
    Metallomics; 2011 Oct; 3(10):971-86. PubMed ID: 21901209
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of intravenous iron in patients with cancer-related anaemia.
    Littlewood TJ; Alikhan R
    Br J Haematol; 2008 Jun; 141(6):751-6. PubMed ID: 18410455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Safety of parenteral iron therapy].
    Kessler M
    Nephrol Ther; 2006 Nov; 2 Suppl 5():S350-5. PubMed ID: 17373283
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diet, nutrition, and cancer.
    Palmer S
    Prog Food Nutr Sci; 1985; 9(3-4):283-341. PubMed ID: 3010379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intravenous iron supplementation in the anaemia of renal and cardiac failure--a double-edged sword?
    Slotki I
    Nephrol Dial Transplant; 2005 Jul; 20 Suppl 7():vii16-23. PubMed ID: 16024827
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Parenteral iron supplementation for the treatment of iron deficiency anemia in children.
    Surico G; Muggeo P; Muggeo V; Lucarelli A; Martucci T; Daniele M; Rigillo N
    Ann Hematol; 2002 Mar; 81(3):154-7. PubMed ID: 11904741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron supplementation in nephrology and oncology: what do we have in common?
    Macdougall IC
    Oncologist; 2011; 16 Suppl 3():25-34. PubMed ID: 21930832
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy and safety of iron supplementation for the elderly patients undergoing hip or knee surgery: a meta-analysis of randomized controlled trials.
    Yang Y; Li H; Li B; Wang Y; Jiang S; Jiang L
    J Surg Res; 2011 Dec; 171(2):e201-7. PubMed ID: 21962806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Upper limit of serum ferritin: misinterpretation of the 2006 KDOQI anemia guidelines.
    Fishbane S
    Semin Dial; 2008; 21(3):217-20. PubMed ID: 18248518
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized trial of intravenous iron supplementation in patients with chemotherapy-related anemia without iron deficiency treated with darbepoetin alpha.
    Pedrazzoli P; Farris A; Del Prete S; Del Gaizo F; Ferrari D; Bianchessi C; Colucci G; Desogus A; Gamucci T; Pappalardo A; Fornarini G; Pozzi P; Fabi A; Labianca R; Di Costanzo F; Secondino S; Crucitta E; Apolloni F; Del Santo A; Siena S
    J Clin Oncol; 2008 Apr; 26(10):1619-25. PubMed ID: 18375891
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of infection with intravenous iron therapy.
    Maynor L; Brophy DF
    Ann Pharmacother; 2007 Sep; 41(9):1476-80. PubMed ID: 17666575
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iron: the new advances in therapy.
    Auerbach M; Goodnough LT; Shander A
    Best Pract Res Clin Anaesthesiol; 2013 Mar; 27(1):131-40. PubMed ID: 23590922
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Iron and Cancer.
    Torti SV; Manz DH; Paul BT; Blanchette-Farra N; Torti FM
    Annu Rev Nutr; 2018 Aug; 38():97-125. PubMed ID: 30130469
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.